Xenon Pharmaceuticals Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Xenon Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$62.8M, a 29.6% decline year-over-year.
  • Xenon Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$213M, a 21.9% decline year-over-year.
  • Xenon Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$182M, a 45.5% decline from 2022.
  • Xenon Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$125M, a 58.9% decline from 2021.
  • Xenon Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$78.9M, a 174% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$182M -$57M -45.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$125M -$46.5M -58.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$78.9M -$50M -174% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$28.8M +$12.8M +30.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$41.6M -$7.1M -20.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$34.5M -$3.79M -12.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 -$30.7M -$7.71M -33.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$23M -$7.25M -46% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 -$15.8M -$28.8M -221% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $13M +$986K +8.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-08
2013 $12M +$16.3M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 -$4.3M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.